Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL243615 | 0.85 | TSHR (0.42) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL3669316 | 0.83 | TSHR (0.46) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL460712 | 0.81 | TDP1 (0.39) | CA1CA2CA7CA9TDP1 | |
| Acetaldehyde SCHEMBL11123828 | 0.80 | TSHR (0.39) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL2187422 | 0.80 | TSHR (0.43) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL8990266 | 0.79 | TDP1 (0.37) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL18271973 | 0.79 | TSHR (0.40) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL562466 | 0.79 | TSHR (0.38) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL170338 | 0.79 | TSHR (0.38) | CA1CA2CA7CA9TDP1 | |
| SCHEMBL18269857 | 0.78 | TDP1 (0.36) | CA1CA2CA7CA9TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6649691-B2 | Imidazolidone carbamate monomers made from vinyl ethylene carbonate reacted with N-aminoethylimidazolidone; emulsion polymerized with acrylate or vinyl acetate; coatings | AIR PRODUCTS POLYMERS, L.P. | 2003-11-18 | — | — | US | claimed |
| US-20030119982-A1 | Wet adhesion monomer and derived copolymers for latex paints | PINSCHMIDT ROBERT KRANTZ (US) | 2003-06-26 | — | — | US | claimed |
| US-6538143-B1 | Reaction product of vinyl ethylene carbonate, methacryloxypropylene carbonate, and allyloxypropylene carbonate; and alkyl or cyclic urea | AIR PRODUCTS POLYMERS, L.P. | 2003-03-25 | — | — | US | claimed |
| EP-1167356-A2 | Wet adhesion monomer and derived copolymers for latex paints | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2002-01-02 | — | — | EP | claimed |
| US-6649691-B2 | Imidazolidone carbamate monomers made from vinyl ethylene carbonate reacted with N-aminoethylimidazolidone; emulsion polymerized with acrylate or vinyl acetate; coatings | AIR PRODUCTS POLYMERS, L.P. | 2003-11-18 | — | — | US | disclosed |
| US-20030119982-A1 | Wet adhesion monomer and derived copolymers for latex paints | PINSCHMIDT ROBERT KRANTZ (US) | 2003-06-26 | — | — | US | disclosed |
| US-6538143-B1 | Reaction product of vinyl ethylene carbonate, methacryloxypropylene carbonate, and allyloxypropylene carbonate; and alkyl or cyclic urea | AIR PRODUCTS POLYMERS, L.P. | 2003-03-25 | — | — | US | disclosed |
| EP-1167356-A2 | Wet adhesion monomer and derived copolymers for latex paints | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030119982-A1 | Wet adhesion monomer and derived copolymers for latex paints | VCL, CLTA, CLTB | CA1 1039/4885CA2 1872/4885CA7 2589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.